Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Finasteride with oral contraceptive improves hair loss in 62% of premenopausal women.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Oral finasteride, combined with drospirenone, improved hair loss in 62% of premenopausal women, with no reported side effects.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Experts made a guide to help doctors evaluate women with too much hair growth.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Low estrogen compared to androgen may cause female hair loss.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

FFA in young women is often missed, and no single treatment works best.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.